|
P < ("P Less Than" Company) provides consulting services to life science companies: Pharmacometric, Pharmacokinetic, Pharmacodynamic, and Statistical Analyses- Pharmacometrics: Analysis of in-progress or completed clinical trials, focussing on effect size and robustness of multiple outcomes rather than hypothesis testing.
- Pharmacokinetic modeling: Mixed-effects (NONMEM) methods analysis of routine or complicated pharmacokinetic clinical/preclinical issues such as linear vs. nonlinear absorption, saturable elimination, metabolite kinetics, sparse data
- Pharmacodynamic modeling: Development and analysis of pharmacodynamic models (both direct and indirect) to develop dosing strategies and to evaluate success of clinical trials.
- Regression models, other statistics: Linear, non-linear, and logistic regression analysis of sparse data, unbalanced samples, or missing data, using mixed-effects approaches when appropriate.
- Clinical trial simulation: Development of dosing and sampling regimens for clinical trials based on available preclinical and clinical data. Simulation of outcomes of clinical trials to evaluate trial design.
Clinical and Regulatory Guidance- Preparation of IND's, including determination and justification of "first dose in humans"
- Design of early- and late-stage clinical trials (with a particular expertise in proof-of-concept trials)
- Working with FDA on behalf of sponsors
- Preparing and reviewing clinical study reports and regulatory documents
Forensic Pharmacometrics- Post hoc analyses of failed phase 2 and phase 3 programs
- Goal is to determine if a different dosing regimen would increase the likelihood of success in a new clinical trial
Due Diligence
|